BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36180645)

  • 1. Clinical value of contralateral breast cancers detected by pre-operative MRI in patients diagnosed with DCIS: a population-based cohort study.
    Keymeulen KBIM; Geurts SME; Kooreman LFS; Duijm LEM; Engelen S; Vanwetswinkel S; Luiten E; Siesling S; Voogd AC; Tjan-Heijnen VCG
    Eur Radiol; 2023 Mar; 33(3):2209-2217. PubMed ID: 36180645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ.
    Wang SY; Long JB; Killelea BK; Evans SB; Roberts KB; Silber A; Gross CP
    Breast Cancer Res Treat; 2016 Jul; 158(1):139-148. PubMed ID: 27287780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.
    Elshof LE; Schaapveld M; Schmidt MK; Rutgers EJ; van Leeuwen FE; Wesseling J
    Breast Cancer Res Treat; 2016 Oct; 159(3):553-63. PubMed ID: 27624164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-operative MRI in patients with ductal carcinoma in situ: Is MRI useful for identifying additional disease?
    Lamb LR; Oseni TO; Lehman CD; Bahl M
    Eur J Radiol; 2020 Aug; 129():109130. PubMed ID: 32634736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pre-operative breast magnetic resonance imaging on contralateral synchronous and metachronous breast cancer detection-A case control comparison study with 1468 primary operable breast cancer patients with mean follow-up of 102 months.
    Wu WP; Chen CY; Lee CW; Wu HK; Chen ST; Wu YT; Lin YJ; Chen DR; Kuo SJ; Lai HW
    PLoS One; 2021; 16(11):e0260093. PubMed ID: 34793522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
    Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
    Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer.
    Choi SH; Choi JS; Han BK; Ko EY; Ko ES; Park KW
    Radiology; 2019 Jul; 292(1):37-48. PubMed ID: 31038406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammographic density and risk of second breast cancer after ductal carcinoma in situ.
    Habel LA; Capra AM; Achacoso NS; Janga A; Acton L; Puligandla B; Quesenberry CP
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2488-95. PubMed ID: 20929881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of breast MRI in women eligible for breast conservation surgery and intra-operative radiation therapy.
    Paudel N; Bethke KP; Wang LC; Strauss JB; Hayes JP; Donnelly ED
    Surg Oncol; 2018 Mar; 27(1):95-99. PubMed ID: 29549911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis.
    Ploumen RAW; de Mooij CM; Gommers S; Keymeulen KBMI; Smidt ML; van Nijnatten TJA
    Eur Radiol; 2023 Aug; 33(8):5423-5435. PubMed ID: 37020070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
    Comstock CE; Gatsonis C; Newstead GM; Snyder BS; Gareen IF; Bergin JT; Rahbar H; Sung JS; Jacobs C; Harvey JA; Nicholson MH; Ward RC; Holt J; Prather A; Miller KD; Schnall MD; Kuhl CK
    JAMA; 2020 Feb; 323(8):746-756. PubMed ID: 32096852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
    Chou SS; Romanoff J; Lehman CD; Khan SA; Carlos R; Badve SS; Xiao J; Corsetti RL; Javid SH; Spell DW; Han LK; Sabol JL; Bumberry JR; Gareen IF; Snyder BS; Gatsonis C; Wagner LI; Wolff AC; Miller KD; Sparano JA; Comstock CE; Rahbar H
    Radiology; 2021 Oct; 301(1):66-77. PubMed ID: 34342501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal carcinoma in situ that involves sclerosing adenosis: high frequency of bilateral breast cancer occurrence.
    Yoshida A; Hayashi N; Akiyama F; Yamauchi H; Uruno T; Kikuchi M; Yagata H; Tsugawa K; Suzuki K; Nakamura S; Tsunoda H
    Clin Breast Cancer; 2012 Dec; 12(6):398-403. PubMed ID: 23083502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of ductal carcinoma in situ in women undergoing screening mammography.
    Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
    J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.
    Innos K; Horn-Ross PL
    Breast Cancer Res Treat; 2008 Oct; 111(3):531-40. PubMed ID: 17978879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added Value of Breast MRI for Preoperative Diagnosis of Ductal Carcinoma In Situ: Diagnostic Performance on 362 Patients.
    Petrillo A; Fusco R; Petrillo M; Triunfo F; Filice S; Vallone P; Setola SV; Rubulotta M; Di Bonito M; Rinaldo M; D'Aiuto M; Brunetti A
    Clin Breast Cancer; 2017 Jun; 17(3):e127-e134. PubMed ID: 28111130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of MRI on high grade Ductal Carcinoma Insitu (HG DCIS) management, are we using the full scope of MRI?
    Hajaj M; Karim A; Pascaline S; Noor L; Patel S; Dakka M
    Eur J Radiol; 2017 Oct; 95():271-277. PubMed ID: 28987679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisit the practice of lymph node biopsy in patients diagnosed as ductal carcinoma in situ before operation: a retrospective analysis of 682 cases and evaluation of the role of breast MRI.
    Lai HW; Chang YL; Chen ST; Chang YJ; Wu WP; Chen DR; Kuo SJ; Liao CY; Wu HK
    World J Surg Oncol; 2021 Sep; 19(1):263. PubMed ID: 34470633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.